PAS for Lower Extremity Rehabilitation in Tetraplegic Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03459885 |
Recruitment Status :
Completed
First Posted : March 9, 2018
Last Update Posted : August 7, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinal Cord Injuries Spinal Cord Diseases | Device: Paired associative stimulation (with eXimia magnetic stimulator and Dantec Keypoint® electroneuromyography device) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 5 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Long-term Paired Associative Stimulation for Rehabilitation of Lower Extremities in Persons With Incomplete Tetraplegia |
Actual Study Start Date : | February 28, 2018 |
Actual Primary Completion Date : | June 28, 2019 |
Actual Study Completion Date : | June 28, 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: PAS
The intervention is given to peripheral nerve - motor cortex pairs selected by the investigator.
|
Device: Paired associative stimulation (with eXimia magnetic stimulator and Dantec Keypoint® electroneuromyography device)
Paired associative stimulation (PAS) administered several times per week for 8 weeks to lower limbs. PAS comprises transcranial magnetic stimulation (eXimia magnetic stimulator, Nexstim Ltd, Helsinki, Finland) and peripheral nerve stimulation (given with Dantec Keypoint® electroneuromyography device (Natus Medical Incorporated, Pleasanton, CA, USA)). |
- Daniels and Worthingham's Muscle Testing [ Time Frame: 2 days after the last stimulation session ]Leg muscle stenght is evaluated on 0-5 scale (0=no movement, 5=normal)
- Daniels and Worthingham's Muscle Testing [ Time Frame: 1 month after the last stimulation session ]leg muscles are evaluated on 0-5 scale

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- cervical incomplete SCI
Exclusion Criteria:
- epilepsy
- metal inclusion in the head area
- pacemaker
- hearing device
- high intracranial pressure

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03459885
Finland | |
BioMag laboratory, Helsinki University Central Hospital | |
Helsinki, Uusimaa, Finland, 00029 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Anastasia Shulga, Principal Investigator, Helsinki University Central Hospital |
ClinicalTrials.gov Identifier: | NCT03459885 |
Other Study ID Numbers: |
UAK 1022001 |
First Posted: | March 9, 2018 Key Record Dates |
Last Update Posted: | August 7, 2019 |
Last Verified: | August 2019 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Spinal Cord Injuries Spinal Cord Diseases Central Nervous System Diseases |
Nervous System Diseases Trauma, Nervous System Wounds and Injuries |